The present invention provides compounds of Formula (I): ##STR00001## or
a stereoisomer or pharmaceutically acceptable salt or hydrate form
thereof, wherein the variables A, B, L.sub.1, L.sub.2, X.sup.1, X.sup.2,
X.sup.3, X.sup.4 and W are as defined herein. The compounds of Formula
(I) are useful as selective inhibitors of serine protease enzymes of the
coagulation cascade and/or contact activation system; for example
thrombin, factor Xa, factor XIa, factor IXa, factor VIIa and/or plasma
kallikrein. In particular, it relates to compounds that are selective
factor XIa inhibitors. This invention also relates to pharmaceutical
compositions comprising these compounds and methods of treating
thromboembolic and/or inflammatory disorders using the same.